📰 Genomic Sciences News
Page 10 - Genomic Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genomic Sciences. Real-time updates on events, politics, business and more.
September 14, 2022
/PRNewswire/ -- Birmingham researchers have identified a potential target for drugs to treat long-term neurological conditions like Alzheimers Disease and...
September 11, 2022
Scientists at the Icahn School of Medicine at Mount Sinai in New York, the National Center for Advancing Translational Sciences (NCATS), and elsewhere have reversed the effects of several life-threatening inherited neurodegenerative diseases called lysosomal storage disorders (LSDs) in patient cells and mice.
September 8, 2022
/PRNewswire/ -- Harmonic Discovery, a therapeutics company building an integrated computational and experimental platform for kinase drug discovery and...
August 30, 2022
Isaralgagene civaparvovec, or ST-920, continued to be generally well tolerated across three dose cohorts in the six treated patients The five longest treated patients exhibited elevated a-Gal A activity
August 18, 2022
Signals firm's commitment to investing in biotech, biology, and computational 'super evolution' breakthroughs...
August 18, 2022
A new study of genes underlying neurodevelopmental differences has uncovered more than 70 that are very strongly associated with autism and more than 250 with strong links to the condition.
August 12, 2022
Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.
August 12, 2022
New York, NY (PRWEB) August 12, 2022 -- Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing
August 11, 2022
Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
August 10, 2022
Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 grant from Stand Up To Cancer to explore therapeutic approaches to lung tumors with mutations in the KRAS gene, an undertaking that could have a significant impact for a large population of cancer patients who currently lack effective treatment options.